TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

• Status: Recruiting
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of California, Davis
• Treatments: Bupivacaine; Ropivacaine

Criteria

Inclusion Criteria:

• Patients ages 18 years or older

• Renal Transplant Recipients

Exclusion Criteria:

• Patients less than 18 years of age

• Pregnant Women

• Prisoners

• Opioid Tolerant Patients taking more than 30 mg/day of oral morphine equivalent analgesia

• Patients on Systemic anti coagulation

• Patients unable to provide consent

• Hypersensitivity to amide-type local anesthetic or any component of the drug formula